Maximum quantity allowed is 999
CAS RN: 319460-85-0 | Product Number: A3479
Axitinib
Purity: >95.0%(T)(HPLC)
- (E)-N-Methyl-2-[[3-[2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl]thio]benzamide
- N-Methyl-2-[[3-[(1E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
50MG |
₹15,000.00
|
Contact Us | 18 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | A3479 |
Purity / Analysis Method | >95.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__2H__1__8N__4OS = 386.47 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 319460-85-0 |
Reaxys Registry Number | 11333336 |
MDL Number | MFCD09837898 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Nonaqueous Titration) | min. 95.0 % |
Melting point | 217.0 to 221.0 °C |
NMR | confirm to structure |
Melting Point | 219 °C |
Maximum Absorption Wavelength | 335(DMSO) nm |
Solubility in water | Insoluble |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | CV5586363 |
References
- Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
- Axitinib for the management of metastatic renal cell carcinoma (a review)
- Clinical Pharmacology of Axitinib (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.